M. Gresik

A Randomized Comparative Study of Purged Autologous Bone Marrow Transplantation Versus Intensive Multiagent Consolidation Chemotherapy in First Remission of Acute Myeloid Leukemia in Children (Pediatric Oncology Group Study—POG 8821)

S. Raimondi, J. Graham-Pole, A. Carroll, 1997 .

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821

S. Raimondi, A. Carroll, Y. Ravindranath, 2000, Leukemia.

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.

F. Behm, S. Raimondi, A. Carroll, 1999, Blood.

Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.

J. Krischer, N. Winick, C. Civin, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intraoral presentation of anaplastic large-cell Ki-1 lymphoma in association with HIV infection.

C. Flaitz, M. Hicks, M. Luna, 1993, Oral surgery, oral medicine, and oral pathology.

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

C. Rooney, C. Bollard, U. Popat, 2000, Human gene therapy.

The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).

J. Krischer, C. Civin, Y. Ravindranath, 1992, Leukemia.